- Home
- HFFG vs CRVS Comparison
HFFG vs CRVS Comparison
Compare HFFG & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFFG
- CRVS
- Stock Information
- Founded
- HFFG 1997
- CRVS 2014
- Country
- HFFG United States
- CRVS United States
- Employees
- HFFG N/A
- CRVS N/A
- Industry
- HFFG Food Distributors
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- HFFG Consumer Discretionary
- CRVS Health Care
- Exchange
- HFFG Nasdaq
- CRVS Nasdaq
- Market Cap
- HFFG 208.3M
- CRVS 305.4M
- IPO Year
- HFFG N/A
- CRVS 2016
- Fundamental
- Price
- HFFG $3.22
- CRVS $3.91
- Analyst Decision
- HFFG
- CRVS Strong Buy
- Analyst Count
- HFFG 0
- CRVS 4
- Target Price
- HFFG N/A
- CRVS $15.00
- AVG Volume (30 Days)
- HFFG 73.7K
- CRVS 1.2M
- Earning Date
- HFFG 08-05-2025
- CRVS 08-05-2025
- Dividend Yield
- HFFG N/A
- CRVS N/A
- EPS Growth
- HFFG N/A
- CRVS N/A
- EPS
- HFFG N/A
- CRVS N/A
- Revenue
- HFFG $1,204,441,000.00
- CRVS N/A
- Revenue This Year
- HFFG $4.27
- CRVS N/A
- Revenue Next Year
- HFFG $4.47
- CRVS N/A
- P/E Ratio
- HFFG N/A
- CRVS N/A
- Revenue Growth
- HFFG 4.71
- CRVS N/A
- 52 Week Low
- HFFG $1.70
- CRVS $1.75
- 52 Week High
- HFFG $4.93
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- HFFG 37.47
- CRVS 55.29
- Support Level
- HFFG $3.03
- CRVS $3.55
- Resistance Level
- HFFG $3.26
- CRVS $4.38
- Average True Range (ATR)
- HFFG 0.19
- CRVS 0.31
- MACD
- HFFG -0.03
- CRVS -0.01
- Stochastic Oscillator
- HFFG 28.37
- CRVS 61.68
About HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).